CR8220A - Composicion de fexofenadina y proceso para su preparacion - Google Patents
Composicion de fexofenadina y proceso para su preparacionInfo
- Publication number
- CR8220A CR8220A CR8220A CR8220A CR8220A CR 8220 A CR8220 A CR 8220A CR 8220 A CR8220 A CR 8220A CR 8220 A CR8220 A CR 8220A CR 8220 A CR8220 A CR 8220A
- Authority
- CR
- Costa Rica
- Prior art keywords
- fexofenadine
- composition
- preparation
- excipients
- filler
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se refiere a una composicion farmaceutica que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma, una celulosa de hidroxipropilo sustituida baja, un relleno, preferiblemente lactosa y opcionalmente otros excipientes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/631,874 US20050065183A1 (en) | 2003-07-31 | 2003-07-31 | Fexofenadine composition and process for preparing |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8220A true CR8220A (es) | 2006-07-27 |
Family
ID=34135544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8220A CR8220A (es) | 2003-07-31 | 2006-01-30 | Composicion de fexofenadina y proceso para su preparacion |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050065183A1 (es) |
EP (1) | EP1651218A1 (es) |
JP (1) | JP2007500682A (es) |
AR (1) | AR045193A1 (es) |
AU (1) | AU2004262914A1 (es) |
BR (1) | BRPI0413186A (es) |
CR (1) | CR8220A (es) |
EC (1) | ECSP066327A (es) |
NO (1) | NO20060991L (es) |
RU (1) | RU2006105720A (es) |
WO (1) | WO2005013987A1 (es) |
ZA (1) | ZA200600519B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040012747A (ko) * | 2001-04-09 | 2004-02-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 펙소페나딘 염산염의 다형체 |
BRPI0418244A (pt) | 2003-12-29 | 2007-04-17 | Sepracor Inc | composto, métodos para aumentar a concentração de d-serina e/ou diminuir a concentração de produtos tóxicos da oxidação de d-serina pela daao em um mamìfero, para tratar a esquizofrenia, para tratar ou prevenir a perda de memória e/ou cognição associadas com o mal de alzheimer, para tratar a ataxia ou para prevenir a perda da função neuronal caracterìstica de doenças neurodegenerativas, para intensificar a aprendizagem, memória e/ou cognição e para tratar dor neuropática, e, composição farmacêutica |
WO2005102999A2 (en) * | 2004-04-26 | 2005-11-03 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
US20060148851A1 (en) * | 2004-09-28 | 2006-07-06 | Shlomit Wizel | Fexofenadine crystal form and processes for its preparation thereof |
US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
EP1808163A1 (en) * | 2005-12-22 | 2007-07-18 | Teva Pharmaceutical Industries Ltd. | Compressed solid dosage forms with drugs of low solubility and process for making the same |
WO2007073389A1 (en) * | 2005-12-22 | 2007-06-28 | Teva Pharmaceutical Industries Ltd. | Compressed solid dosage forms with drugs of low solubility and process for making the same |
US20070148245A1 (en) * | 2005-12-22 | 2007-06-28 | Ilan Zalit | Compressed solid dosage forms with drugs of low solubility and process for making the same |
US20070264330A1 (en) * | 2006-05-15 | 2007-11-15 | Bo Ragnar-Tolf | Pharmaceutical formulations of pimavanserin |
RU2453315C2 (ru) * | 2010-08-17 | 2012-06-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения аллергических заболеваний |
BR112013007469B1 (pt) * | 2010-09-21 | 2020-03-31 | Intekrin Therapeutics, Inc. | Composições farmacêuticas antidiabéticas sólidas, seu uso e método de preparação, método para preparar um produto de granulação e composição precursora farmacêutica |
JP2013119540A (ja) * | 2011-12-08 | 2013-06-17 | Nipro Corp | 固形医薬組成物およびその製造法 |
WO2013125350A1 (ja) * | 2012-02-23 | 2013-08-29 | フロイント産業株式会社 | 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠 |
JP6184727B2 (ja) * | 2013-04-15 | 2017-08-23 | ロート製薬株式会社 | 医薬組成物 |
SG11201707276PA (en) | 2015-03-09 | 2017-10-30 | Intekrin Therapeutics Inc | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
CN106137989A (zh) * | 2016-07-20 | 2016-11-23 | 南通雅本化学有限公司 | 一种基于盐酸非索非那定的药物组合物 |
AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
JP6410895B2 (ja) * | 2017-07-26 | 2018-10-24 | ロート製薬株式会社 | 医薬組成物 |
WO2022123511A1 (en) * | 2020-12-11 | 2022-06-16 | Cellix Bio Private Limited | A composition comprising fexofenadine |
GB202212656D0 (en) | 2022-08-31 | 2022-10-12 | Novumgen Ltd | An orodispersible tablet of fecofenadine and it process of preparation |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
JPS52151717A (en) * | 1976-06-09 | 1977-12-16 | Shionogi & Co Ltd | Sugar coating on solid preparations |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
JPS6183123A (ja) * | 1984-09-28 | 1986-04-26 | Taisho Pharmaceut Co Ltd | 抗喘息剤 |
US4996061A (en) * | 1987-10-07 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
US4929605A (en) * | 1987-10-07 | 1990-05-29 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol derivatives |
AU679910B2 (en) * | 1992-05-11 | 1997-07-17 | Merrell Pharmaceuticals Inc. | Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient |
DE69415319T2 (de) * | 1993-06-24 | 1999-06-10 | Albany Molecular Research, Inc., Albany, N.Y. | Verfahren zur herstellung von piperidinderivaten |
HUP9802086A3 (en) * | 1995-02-28 | 2001-02-28 | Aventis Pharmaceuticals Inc Br | Pharmaceutical composition for piperidinoalkanol compounds |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
JPH09315971A (ja) * | 1996-05-28 | 1997-12-09 | Daito Kk | テルフェナジン含有錠剤製剤 |
DK1586314T3 (da) * | 1996-11-15 | 2011-06-20 | Ajinomoto Kk | Nateglinide tablet sammensætning |
HRP980532B1 (en) * | 1998-10-02 | 2005-06-30 | Pliva | Novel crystalline torasemide modification |
WO2000038650A1 (en) * | 1998-12-23 | 2000-07-06 | Alza Corporation | Gastric retention dosage form having multiple layers |
EP1054019A1 (en) * | 1999-05-18 | 2000-11-22 | Shin-Etsu Chemical Co., Ltd. | Low-substituted hydroxypropyl cellulose |
US6500459B1 (en) * | 1999-07-21 | 2002-12-31 | Harinderpal Chhabra | Controlled onset and sustained release dosage forms and the preparation thereof |
US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
US20030021849A1 (en) * | 2001-04-09 | 2003-01-30 | Ben-Zion Dolitzky | Polymorphs of fexofenadine hydrochloride |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
-
2003
- 2003-07-31 US US10/631,874 patent/US20050065183A1/en not_active Abandoned
-
2004
- 2004-07-30 JP JP2006521550A patent/JP2007500682A/ja not_active Withdrawn
- 2004-07-30 RU RU2006105720/15A patent/RU2006105720A/ru unknown
- 2004-07-30 EP EP04763678A patent/EP1651218A1/en not_active Withdrawn
- 2004-07-30 AU AU2004262914A patent/AU2004262914A1/en not_active Abandoned
- 2004-07-30 WO PCT/EP2004/008600 patent/WO2005013987A1/en not_active Application Discontinuation
- 2004-07-30 BR BRPI0413186-0A patent/BRPI0413186A/pt not_active Application Discontinuation
- 2004-08-02 AR ARP040102748A patent/AR045193A1/es unknown
-
2006
- 2006-01-18 ZA ZA200600519A patent/ZA200600519B/en unknown
- 2006-01-27 EC EC2006006327A patent/ECSP066327A/es unknown
- 2006-01-30 CR CR8220A patent/CR8220A/es not_active Application Discontinuation
- 2006-02-28 NO NO20060991A patent/NO20060991L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AR045193A1 (es) | 2005-10-19 |
BRPI0413186A (pt) | 2006-10-03 |
WO2005013987A1 (en) | 2005-02-17 |
ECSP066327A (es) | 2006-07-28 |
AU2004262914A1 (en) | 2005-02-17 |
ZA200600519B (en) | 2007-01-31 |
RU2006105720A (ru) | 2007-09-10 |
US20050065183A1 (en) | 2005-03-24 |
JP2007500682A (ja) | 2007-01-18 |
EP1651218A1 (en) | 2006-05-03 |
NO20060991L (no) | 2006-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8220A (es) | Composicion de fexofenadina y proceso para su preparacion | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
UY29445A1 (es) | Composiciones para la transmisión transmucosa oral de la metformina | |
UY30537A1 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
AR041089A1 (es) | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas | |
ECSP034603A (es) | Combinaciones sinergicas que comprenden un inhibidor de renina para enfermedades cardiovasculares | |
EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
WO2006082523A3 (en) | Pharmaceutical sustained release composition of metformin | |
HN1999000183A (es) | Preparado farmaceuticos de moxifloxacina | |
BRPI0416216A (pt) | composto de glicoimidazol e polihidroxiciclohexenila e método para sintetizar composto de glicoimidazol e polihidroxiciclohexenila, métodos para inibir glicocerebrosidase, para aumentar a atividade de glicocerebrosidase e para estabilizar glicocerebrosidade, composição farmacêutica, métodos para inibir uma -glicosidade, e para tratar doença de gaucher, derivado de glicoimidazol e derivados de polihidroxiciclohexilamina | |
AR054806A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
EA200700637A1 (ru) | Соли донепезила, подходящие для получения фармацевтических композиций | |
CO6382133A2 (es) | Metodo para tratar o prevenir la trombosis usando etexilato de dabigatran o una sal del mismo con una eficacia mejorada sobre la terapia con warfarina convencional | |
UA87515C2 (ru) | Фармацевтическая композиция толтеродина с пролонгированным высвобождением | |
AR073265A1 (es) | Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio | |
WO2008013860A3 (en) | Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use | |
AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
AR032479A1 (es) | Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina | |
CO6382170A2 (es) | Composiciones farmacéuticas que comprenden 3-(1.h.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quinazolin-4-il]pirrol-2,5-diona o una sal farmacéuticamente aceptable del mismo y procesos para su producción. | |
PT1490049E (pt) | Citalopram para o tratamento da pre3ssao sanguinia elevada. | |
MXPA06002778A (es) | Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |